v3.26.1
Loss Per Common Share (Tables)
6 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following common stock equivalents were excluded from the calculation of diluted net loss per share applicable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:
As of June 30,
20262025
Anti-dilutive common stock equivalents:
October 2024 Common Warrants119,933119,933 
March 2025 Common Warrants415,846415,846 
July 2025 Common Warrants153,854— 
January 2026 Series A Common Warrants1,346,346— 
January 2026 Series B Common Warrants1,346,346— 
January 2026 Series C Common Warrants1,346,346— 
Stock options outstanding112,236121,420
Unvested RSAs— — 
Unvested RSUs6,21714,175 
Total anti-dilutive common stock equivalents4,847,124671,374